Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (322)	2/18/2000 1:51:00 PM
From: Return to Sender	Read Replies (1) \| Respond to of 1142

Mike I got in ELN at 23 and change a few months ago. Like the idiot I sometimes am I traded out with a small profit. I would say yes to buying on dips. ELN has some tremendous drug development programs and they own a significant number of shares in a number of hot biotech issues. It is perhaps one of the most undervalued stocks in the sector but you still should buy on dips only. RTS

To: Mike McFarland who wrote (322)	2/19/2000 1:29:00 AM
From: Don England	Read Replies (1) \| Respond to of 1142

mike, you probably know more about them than i do. 10% of my portfolio is eln. they seeem like a rock right here. dips - i doubt it... have established a really nice base around 36. products in pipeline, esp. the non-opiod pain med, and ownership of postions in other bios, plus cash rich, make them seem like the blue chip of my holdings. i'd buy more here if i didn't feel well-weighted. expected a slaughter but was up 4% for the day. took no cash off the table. nibbled on dips. had considered lightening on cyto and tgen, but afraid to get left at the altar in the cause of grabbing a few thousand in quickie profits. looking at aria for mon. am. don